~~<i id='031BC3904C'><strike id='031BC3904C'><tt id='031BC3904C'><pre id='031BC3904C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：hotspot 2025-10-01 12:35:10 - browse：5163

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Assistant physicians can help address the primary care shortage

Wikipedia

focus

leisure time

focus

hotspot

knowledge

SophieGogginsoftheNationalMuseumsScotlandinEdinburghviewsDollytheSheepduringtheopeningofamajornewdev

WSS

Chamber of Commerce, DOJ clash in court over drug prices

Patients, doctors press FTC to beef up hospital merger scrutiny

STAT series 'Denied by AI' wins major journalism prizes

Fertility clinic egg and embryo storage is a disaster

Covid’s new normal has set in amid another rise in cases

David Liu startup to focus on CRISPR delivery

hotspot

entertainment

Wikipedia

Virginia high school admissions case could be legal follow

Oak Street deal isn't the answer to health care's woes

Jerome Adams on the need for new antivirals for Covid

Cherokee Nation medical school graduates its first class

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why the quest to eradicate polio has stumbled

Trump demands the U.S. pay no more for drugs than other countries … again

WuXi Biologics execs register to lobby as Congress comes for the company

Medicare details structure of new drug price negotiation program

Chamber of Commerce, DOJ clash in court over drug prices

focus

Assistant physicians can help address the primary care shortage

Akili changes sales model for its ADHD video game treatment

Neurocrine congenital adrenal hyperplasia trial succeeds

Akili changes sales model for its ADHD video game treatment

Supreme Court to hear if Covid misinformation is protected speech

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

leisure time

focus

hotspot

knowledge